SCHEMBL5223578

SCHEMBL5223578

CCCCn1ccc2c(N3CCCC3=O)cc(C(=O)O)cc21

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.45
CTSD P07339 1/20 0.45
BACE2 Q9Y5Z0 1/20 0.45
ALDH1A1 P00352 3/20 0.40
CYP2C9 P11712 4/20 0.40
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
HPGD P15428 2/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.38
GAA P10253 1/20 0.37
MCL1 Q07820 1/20 0.37
USP2 O75604 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219794 0.97 BACE1 (0.44) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5216936 0.91 BACE1 (0.44) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5225090 0.89 BACE1 (0.53) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5389115 0.88 BACE1 (0.43) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5219489 0.83 ALDH1A1 (0.47) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5396304 0.81 ALDH1A1 (0.39) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5222810 0.79 BACE1 (0.51) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL5395792 0.77 ALDH1A1 (0.38) ALDH1A1HSD17B10
SCHEMBL5222417 0.73 CYP2C9 (0.42) BACE1CTSDBACE2ALDH1A1CYP2C9
SCHEMBL3350056 0.72 ALDH1A1 (0.46) ALDH1A1HPGDMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed